Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
Open Access
- 18 June 2020
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 8 (6) , 166
Abstract
Atherosclerosis is a multifactorial disease of the cardiovascular system associated with aging, inflammation, and oxidative stress. An important role in the development of atherosclerosis play elevated plasma lipoproteins. A number of external factors (smoking, diabetes, infections) can also contribute to the development of the disease. For a long time, atherosclerosis remains asymptomatic, therefore, the search for early markers of the disease is critical for the timely management and better outcomes for patients. Mitochondrial dysfunction and mitochondrial DNA (mtDNA) damage appear to connect different aspects of atherosclerosis pathogenesis. To date, multiple lines of research have demonstrated the strong association of mitochondrial dysfunction with the development of various human diseases. Therapies aimed at restoring the mitochondrial function are being actively developed, and are expected to broaden the therapeutic possibilities for several chronic human diseases. The development of such therapies depends on our understanding of the functional roles of different mtDNA variants associated with one or another disorder, and the molecular mechanisms linking mitochondrial dysfunction with a given pathological feature. These questions are, however, challenging and require future intensive research. This review summarizes the recent studies and describes the central processes of the development of atherosclerosis, and shows their relationship with mitochondrial dysfunction. One of the promising therapeutic approaches for future atherosclerosis treatments is the use of mitochondria-targeted antioxidants. Future studies should focus on characterizing the mechanisms of mitochondrial involvement in cardiovascular pathologies to better direct the search for novel therapies.Keywords
Funding Information
- Russian Science Foundation (19-15-00297)
This publication has 78 references indexed in Scilit:
- Mitochondrial turnover in the heartBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and BehaviorScience Signaling, 2009
- Endothelial Injury and Repair: A Novel Theory for AtherosclerosisAngiology, 2008
- Why Have Antioxidants Failed in Clinical Trials?The American Journal of Cardiology, 2008
- Cytokines in Atherosclerosis: Pathogenic and Regulatory PathwaysPhysiological Reviews, 2006
- High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase–Regulated Cyclooxygenase-2 PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Class A Scavenger Receptor-mediated Adhesion and Internalization Require Distinct Cytoplasmic DomainsJournal of Biological Chemistry, 2003
- Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in YouthArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patientsBiochemical and Biophysical Research Communications, 1989
- Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation, 1981